• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Severe Dengue

Severe Dengue - 15 Studies Found

Active, not recruiting : Association of Host Genetics With Vaccine Efficacy and Study of Immune Correlates of Risk From a Tetravalent Dengue Vaccine
:
  • Dengue Fever
  • Dengue Haemorrhagic Fever

: 2016-06-29
Completed : Immunogenicity and Safety of a Tetravalent Dengue Vaccine Booster Injection in Subjects Who Previously Completed a 3-dose Schedule
:
  • Dengue Fever
  • Dengue Hemorrhagic Fever

: 2016-07-01
:
  • Biological: CYD Dengue Vaccine (5 dose formulation)

Enrolling by invitation : Cohort Event Monitoring for Dengvaxia®, CYD-TDV Dengue Vaccine
:
  • Dengue Fever
  • Dengue Hemorrhagic Fever

: 2016-10-27
Completed : Study of a Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 11 Years in Malaysia
:
  • Dengue Fever
  • Dengue Hemorrhagic Fever

: 2010-12-03
:
  • Biological: Live, attenuated, recombinant dengue serotypes 1, 2, 3, and 4 vi

Not yet recruiting : Study of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Adacel® in Healthy Subjects
:
  • Dengue Fever
  • Dengue Hemorrhagic Fever

: 2016-12-12
:
  • Biological: CYD Dengue Vaccine

Completed : Study of a Tetravalent Dengue Vaccine in Healthy Adults in Australia
:
  • Dengue Fever
  • Dengue Hemorrhagic Fever

: 2010-05-27
:
  • Biological: Live, attenuated, recombinant dengue serotypes 1, 2, 3, & 4

Completed : A Study of Dengue Vaccine in Healthy Toddlers Aged 12 to 15 Months in the Philippines
:
  • Dengue Fever
  • Dengue Hemorrhagic Fever

: 2010-02-05
:
  • Biological: Live, attenuated, recombinant dengue serotypes 1, 2, 3 and 4 vir

Active, not recruiting : Immunogenicity and Safety of 3-Dose and Booster Dose of Tetravalent Dengue Vaccine in Healthy Subjects 9 to 50 Years of Age
:
  • Dengue Fever
  • Dengue Hemorrhagic Fever

: 2015-12-09
:
  • Biological: CYD Dengue Vaccine

Active, not recruiting : Study of a Booster Dose of a Tetravalent Dengue Vaccine in Subjects Who Previously Completed the 3-dose Schedule
:
  • Dengue Fever
  • Dengue Hemorrhagic Fever

: 2015-12-03
:
  • Biological: CYD Dengue Vaccine (5-dose formulation)

Completed : Safety of and Immune Response to DEN4 Vaccine Component Candidate for Dengue Virus
:
  • Dengue Shock Syndrome
  • Dengue Hemorrhagic Fever

: 2009-06-11
:
  • Biological: DEN4 Vaccine Candidate

Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.